FrontPage is India's Stock Market Social Network
Join 50,000+ Traders and Investors
Find answers to all your questions on live BIOCON message board: Is BIOCON buy or sell? Should I buy BIOCON shares? Why are BIOCON shares falling? Should I invest in BIOCON stock?
forum
BIOCON Share Price Discussion
Biocon Ltd.
NSE: BIOCON | BSE: 532523 | ISIN: INE376G01013 | Sector: Pharmaceuticals and health care
N
Reputation: 4,721 • Jul 9 7:13 AM
Top stocks to bet on: ICICI Bank, Biocon, Rallis India can return 15-20% in near term
On the upside, the Nifty needs to sustain 10,800 for the uptrend to continue towards 11,100 and then possibly 11,350.
On the upside, the Nifty needs to sustain 10,800 for the uptrend to continue towards 11,100 and then possibly 11,350.
Moneycontrol
Like
Reply
NSE:BIOCON price when posted: 405.75
Recent posts in BIOCON
India can play a big role Covid vaccine manufacturing: Kiran Mazumdar-Shaw
Speaking at the ET Global Townhall, the biopharma sector entrepreneur said the countrys science laboratories have already shown tremendous potential in developing Covid-19 testing kits during the past 3-4 months.
Speaking at the ET Global Townhall, the biopharma sector entrepreneur said the countrys science laboratories have already shown tremendous potential in developing Covid-19 testing kits during the past 3-4 months.
The Economic Times
Like
Reply
T
Reputation: 137,973 • Today 11:10 AM
Today's performance
From
406 to 400
890to 880
21700ce
From
370to 400
Twice
From 183 to 189
Extra level - escorts b, TVs motor , hindpetro , Asian paints
💵💵💵💵💵🏆🏆🏆💵💵💵💵💵
Our clients faith is our wealth
💵💵💵💵💵🏆🏆🏆🏆💵💵💵...
Read more...
Like
Reply
N
Reputation: 4,721 • Today 7:36 AM
Share market update: Midcap stocks rise; Honeywell Automation soars 11%
The S&P BSE MidCap index was trading 1.28 per cent up at 14195.78.
The S&P BSE MidCap index was trading 1.28 per cent up at 14195.78.
The Economic Times
Like
Reply
V
Reputation: 5,073 • Today 1:18 AM
Performance of intraday stock 4- aug.
All trigerred but no target hit no stoploss hit. Exited soke in little profit some in little loss. Overall little loss.
Like
Reply
N
Reputation: 4,721 • Aug 5 9:21 AM
India to unveil new Pharma R&D policy, incentivise scientists on monetisation
Announcing this on Wednesday, Indias Pharma Secretary PD Vaghela said the new policy will also insist on globally benchmarking the Research & Development ecosystem by getting rid of archaic laws and rewarding the scientists through industry-academia linkage.
Announcing this on Wednesday, Indias Pharma Secretary PD Vaghela said the new policy will also insist on globally benchmarking the Research & Development ecosystem by getting rid of archaic laws and rewarding the scientists through industry-academia linkage.
The Economic Times
Like
Reply